Social Media Ideas for Vogenx

Latest updates for Vogenx

Fresh curated links around Vogenx are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 month ago

Vogenx joins the IPO queue to fund phase 2-stage metabolic drug

Vogenx has joined the growing queue for the Nasdaq, as the metabolic biotech eyes an IPO to fund its SGLT1 inhibitor.

Read source

medcitynews.com /3 weeks ago

Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs

Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Vogenx

medcitynews.com

Recent coverage from public sources

Public source

fiercebiotech.com